Evidence map›Paper›PMID 32760085›Full record

ArticlePloS one2020

An in vitro study to assess the effect of hyaluronan-based gels on muscle-derived cells: Highlighting a new perspective in regenerative medicine.

Antonietta Stellavato, Lucrezia Abate, Valentina Vassallo, Maria Donniacuo, Barbara Rinaldi, Chiara Schiraldi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The Extract ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Research Progress on Bioactive Factors against Skin Aging.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Medial Gastrocnemius Strain: Clinical Aspects and Algorithmic Approach.Medical journal of the Islamic Republic of Iran · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Optimization of growth ofFrontiers in bioengineering and biotechnology · 2022
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Antonietta StellavatoDepartment of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio, Naples, Italy.
Lucrezia AbateDepartment of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio, Naples, Italy.
Valentina VassalloDepartment of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio, Naples, Italy.
Maria DonniacuoUnit of Pharmacology, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Barbara RinaldiUnit of Pharmacology, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Chiara SchiraldiDepartment of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio, Naples, Italy.ORCID 0000-0002-1066-843X
University of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronan (HA) is a nonsulfated glycosaminoglycan that has been widely used for biomedical applications. Here, we have analyzed the effect of HA on the rescue of primary cells under stress as well as its potential to recover muscle atrophy and validated the developed model in vitro using primary muscle cells derived from rats. The potentials of different HAs were elucidated through comparative analyses using pharmaceutical grade a) high (HHA) and b) low molecular weight (LHA) hyaluronans, c) hybrid cooperative complexes (HCC) of HA in three experimental set-ups. The cells were characterized based on the expression of myogenin, a muscle-specific biomarker, and the proliferation was analyzed using Time-Lapse Video Microscopy (TLVM). Cell viability in response to H2O2 challenge was evaluated by 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, and the expression of the superoxide dismutase enzyme (SOD-2) was assessed by western blotting. Additionally, in order to establish an in vitro model of atrophy, muscle cells were treated with tumor necrosis factor-alpha (TNF-α), along with hyaluronans. The expression of Atrogin, MuRF-1, nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-kB), and Forkhead-box-(Fox)-O-3 (FoxO3a) was evaluated by western blotting to elucidate the molecular mechanism of atrophy. The results showed that HCC and HHA increased cell proliferation by 1.15 and 2.3 folds in comparison to un-treated cells (control), respectively. Moreover, both pre- and post-treatments of HAs restored the cell viability, and the SOD-2 expression was found to be reduced by 1.5 fold in HA-treated cells as compared to the stressed condition. Specifically in atrophic stressed cells, HCC revealed a noteworthy beneficial effect on the myogenic biomarkers indicating that it could be used as a promising platform for tissue regeneration with specific attention to muscle cell protection against stressful agents.

Indexed as

AnimalsCell ProliferationCell SurvivalCulture MediaGelsHumansHyaluronic AcidHydrogen PeroxideIntravital MicroscopyMolecular WeightMuscle Fibers, SkeletalMuscular AtrophyMyogeninOxidative StressPrimary Cell CultureRatsCulture MediaGelsHyaluronic AcidHydrogen PeroxideMyogeninMyog protein, ratSuperoxide DismutaseSuperoxide Dismutase 2Tumor Necrosis Factor-alpha

Identifiers

PMID32760085
PMCPMC7410276
OpenAlexW3047971855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.